BLU - Hot Stocks: COVID vaccine makers rise; JWN FTCH set lows; ARNA BLU skyrocket; KLIC drops

On a weak day for the overall equity market, COVID vaccine makers presented a bright spot on Monday. New data showing potential against the Omicron variant gave strength to Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA), Johnson & Johnson (NYSE:JNJ) and Novavax (NASDAQ:NVAX). Bellus Health (NASDAQ:BLU) also benefited from clinical data, although for a completely different product. The stock jumped nearly 50% on strong results from a trial of its experimental cough treatment. Elsewhere in the drug development space, Arena Pharma (NASDAQ:ARNA) represented another major winner on the session. The stock soared on the news that it has agreed to be purchased by Pfizer (PFE). Turning to some of the day's biggest decliners, Kulicke and Soffa (NASDAQ:KLIC) plunged on news of insider selling. At the same time, a sell-off in the retail sector brought Nordstrom (NYSE:JWN) and Farfetch (NYSE:FTCH) to fresh 52-week lows. Sector In Focus Shares of COVID vaccine makers

For further details see:

Hot Stocks: COVID vaccine makers rise; JWN, FTCH set lows; ARNA, BLU skyrocket; KLIC drops